Next Article in Journal
Antispasmodic Activity of Semi-Synthetic Secoisopimarane Derivatives
Previous Article in Journal
SARs of the Antiprotozoal Potency of Diaryl Substituted Bicyclic Bases
Article Menu

Article Versions

Export Article

Open AccessAbstract
Sci. Pharm. 2009, 77(Posters (PO)), 214; doi:10.3797/scipharm.oephg.21.PO-15 (registering DOI)

Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives

Institute of Pharmaceutical Sciences, Karl-Franzens-University of Graz, Universitätsplatz 1, 8010 Graz, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Download PDF [218 KB, uploaded 12 May 2017]
Note: In lieu of an abstract, this is an excerpt from the first page.


Every year about half a million people are infected with Human African Trypanosomiasis (HAT) and more than 40.000 people die from this disease [1]. Infections with Trypanosoma brucei rhodesiense, which is the more virulent of the two causative organisms, can only be treated with two drugs, suramin and melarsoprol, which can cause severe side effects and which have to be administered by painful injections.[...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

WEIS, R.; FAIST, J.; SEEBACHER, W. Antitrypanosomal Activity of 4-Aminobicyclo[2.2.2]octane Derivatives. Sci. Pharm. 2009, 77, 214.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top